CTSF Protein (Cathepsin F)

CTSF Protein (Cathepsin F)

Introduction

Ctsf Protein (Cathepsin F) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>CTSF (Cathepsin F)</td></tr>
<tr><th>Gene</th><td>[CTSF](/genes/ctsf)</td></tr>
<tr><th>UniProt ID</th><td>[Q9UJW0](https://www.uniprot.org/uniprot/Q9UJW0)</td></tr>
<tr><th>NCBI Gene ID</th><td>[8722](https://www.ncbi.nlm.nih.gov/gene/8722)</td></tr>
<tr><th>Molecular Weight</th><td>52 kDa (462 amino acids)</td></tr>
<tr><th>Subcellular Localization</th><td>Lysosome, endosome</td></tr>
<tr><th>Protein Family</th><td>Cysteine protease, Papain family (C1)</td></tr>
<tr><th>Brain Expression</th><td>Neurons, microglia, astrocytes</td></tr>
<tr><th>Associated Diseases</th><td>[CLN10/Neuronal Ceroid Lipofuscinosis](/diseases/neuronal-ceroid-lipofuscinosis), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Overview

...

CTSF Protein (Cathepsin F)

Introduction

Ctsf Protein (Cathepsin F) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>CTSF (Cathepsin F)</td></tr>
<tr><th>Gene</th><td>[CTSF](/genes/ctsf)</td></tr>
<tr><th>UniProt ID</th><td>[Q9UJW0](https://www.uniprot.org/uniprot/Q9UJW0)</td></tr>
<tr><th>NCBI Gene ID</th><td>[8722](https://www.ncbi.nlm.nih.gov/gene/8722)</td></tr>
<tr><th>Molecular Weight</th><td>52 kDa (462 amino acids)</td></tr>
<tr><th>Subcellular Localization</th><td>Lysosome, endosome</td></tr>
<tr><th>Protein Family</th><td>Cysteine protease, Papain family (C1)</td></tr>
<tr><th>Brain Expression</th><td>Neurons, microglia, astrocytes</td></tr>
<tr><th>Associated Diseases</th><td>[CLN10/Neuronal Ceroid Lipofuscinosis](/diseases/neuronal-ceroid-lipofuscinosis), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Overview

Cathepsin F (CTSF) is a lysosomal cysteine protease belonging to the papain family that plays essential roles in intracellular protein degradation, [autophagy](/entities/autophagy), and cellular homeostasis. As one of the most abundant lysosomal proteases, CTSF is crucial for degrading misfolded proteins, damaged organelles, and various cellular substrates within the lysosomal compartment[@mole2024]. Mutations in the CTSF gene cause CLN10 disease (neuronal ceroid lipofuscinosis type 10), a severe neurodegenerative disorder characterized by accumulation of lipofuscin-like ceroid deposits in [neurons](/entities/neurons)[@kousi2012].

Beyond its well-established role in CLN10 disease, emerging research implicates CTSF in the pathogenesis of more common neurodegenerative disorders, including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease). The protease participates in [amyloid-beta](/proteins/amyloid-beta) degradation, [alpha-synuclein](/proteins/alpha-synuclein) processing, and regulation of the autophagy-lysosome pathway—all processes central to neurodegeneration[@bennett2020].

Structure

Cathepsin F is synthesized as a preproenzyme and undergoes multiple processing steps to achieve its mature, active form:

Primary Structure

• Length: 462 amino acids (preproenzyme)
• Molecular weight: ~52 kDa (preproenzyme), ~26 kDa (mature enzyme)
• Signal peptide: Amino acids 1-20

Domain Organization

Signal peptide (1-20): Directs cotranslational translocation into the endoplasmic reticulum[@turk2012].

Propeptide (21-215): N-terminal prosegment that blocks the active site and maintains zymogen latency. This includes an ER retention signal (KDEL-like) in some splice variants.

Mature protease domain (216-462): Catalytic domain containing the characteristic papain-family structure:

• Two EER domains (extended external regions)
• Two globular domains (L and R)
• Active site cleft between domains

Catalytic Triad

• Cysteine at position 138 (in mature enzyme): Nucleophilic residue
• Histidine at position 279: General base
• Asparagine at position 299: Stabilizes histidine

Key Structural Features

• Occluding loop: Differentiates cathepsin F from other cathepsins
• Glycosylation sites: N-linked carbohydrates for stability
• Active site pocket: Prefers hydrophobic residues at P2 position

Normal Function

Lysosomal Protein Degradation

Cathepsin F is one of the most active lysosomal cysteine proteases:

Substrate Specificity

• Cleaves proteins with broad specificity
• Prefers hydrophobic and aromatic residues at P2 position
• Degrades extracellular matrix proteins
• Processes antigen peptides for MHC presentation

Role in Autophagy

• Essential for proper autophagosome-lysosome fusion
• Degrades sequestered cytoplasmic components
• Processes autophagy receptors and regulators

Immune Function

Antigen Processing

• Generates antigenic peptides for MHC class II presentation
• Processes extracellular proteins acquired by phagocytosis
• Involved in invariant chain cleavage

Inflammatory Responses

• Released from activated macrophages
• Can degrade extracellular matrix
• Modulates cytokine activity

Cellular Homeostasis

• Cleaves misfolded proteins destined for degradation
• Processes growth factor receptors
• Regulates cell survival pathways

Role in Neurodegenerative Diseases

CLN10 Disease (Neuronal Ceroid Lipofuscinosis)

CLN10 caused by CTSF mutations is the most severe form of neuronal ceroid lipofuscinosis:

Genetics

• Autosomal recessive inheritance
• Over 20 pathogenic variants identified
• Most common: nonsense mutations leading to truncated protein

Pathology

• Accumulation of ceroid lipofuscin in lysosomes
• Massive neuronal loss, particularly in [cortex](/brain-regions/cortex) and cerebellum
• Progressive atrophy of brain structures

Clinical Features

• Infantile onset (most severe form)
• Severe developmental regression
• Seizures, motor dysfunction
• Blindness due to retinal degeneration
• Death within 2-3 years

Alzheimer's Disease

CTSF plays complex roles in AD pathogenesis:

Amyloid-Beta Metabolism

• CTSF can degrade Aβ peptides in vitro
• Reduced CTSF activity in AD brains may contribute to Aβ accumulation
• Therapeutic strategies to enhance CTSF considered

Lysosomal Dysfunction

• CTSF activity reduced in AD neurons
• Lysosomal membrane permeabilization releases CTSF to cytosol
• Cytosolic CTSF can trigger [apoptosis](/entities/apoptosis)

[Tau](/proteins/tau) Pathology

• CTSF can degrade certain tau isoforms
• Impaired CTSF may contribute to tau aggregation

Parkinson's Disease

Alpha-Synuclein Processing

• CTSF can cleave α-synuclein
• Altered CTSF activity may affect Lewy body formation
• May influence prion-like propagation

Lysosomal Function

• Reduced CTSF activity in PD substantia nigra
• Contributes to impaired autophagic clearance
• May affect mitochondrial quality control

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis

• CTSF activity altered in motor neurons
• May contribute to protein aggregate accumulation

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin) affects lysosomal function
• CTSF may help clear huntingtin aggregates

Therapeutic Implications

Biomarker Potential

• CSF CTSF activity: Could serve as lysosomal function marker
• Blood CTSF: Peripheral indicator of system-wide lysosomal health
• Activity ratios: CTSF/cathepsin B ratios in disease states

Therapeutic Strategies

Enzyme Replacement Therapy

• Recombinant CTSF delivery
• Challenges: [Blood-brain barrier](/entities/blood-brain-barrier) penetration
• AAV-mediated gene therapy in development

Small Molecule Activators

• Enhance residual CTSF activity
• Must balance beneficial and potential detrimental effects
• Predrug approaches for lysosomal delivery

Substrate Reduction Therapy

• Reduce accumulation of harmful substrates
• Support other lysosomal enzymes

Drug Development

• Lysosomal delivery vectors: Conjugating CTSF to targeting moieties
• Gene therapy: AAV vectors encoding CTSF
• Combination approaches: CTSF with other lysosomal enzymes

Interactions and Pathways

Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| CTSD | Protease network | Coordinated protein degradation |
| CTSB | Protease network | Overlapping substrate specificity |
| LAMP2 | Lysosomal targeting | Lysosomal localization |
| GBA | Gaucher disease gene | Lysosomal function |

Signaling Pathways

• Autophagy-lysosome pathway: CTSF essential for completion
• MHC class II antigen presentation: Peptide generation
• Apoptosis pathway: CTSF release triggers caspase activation

Research Techniques

Detection Methods

• Activity assays: Fluorogenic substrates (Z-Phe-Arg-AMC)
• Immunoblotting: Pro-CTSF and mature forms
• Immunohistochemistry: Cellular localization in brain
• Mass spectrometry: Substrate profiling

Model Systems

• CTSF knockout mice: Viable, show accumulation of lipofuscin
• Patient-derived iPSCs: Neurons modeling CLN10
• AAV models: Viral-mediated CTSF knockdown

Background

The study of Ctsf Protein (Cathepsin F) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• CTSF Gene
• Lysosomes
• [Cathepsin B](/proteins/cathepsin-b)
• [Neuronal Ceroid Lipofuscinosis](/diseases/neuronal-ceroid-lipofuscinosis)
• [Autophagy](/mechanisms/autophagy-lysosome-neurodegeneration)
• [Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-disease-mechanisms)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease-mechanisms)
• [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)